Evidence map›Paper›PMID 34895157›Full record

ArticleBMC infectious diseases2021

Monitoring for COVID-19 by universal testing in a homeless shelter in Germany: a prospective feasibility cohort study.

Andreas K Lindner, Navina Sarma, Luise Marie Rust, Theresa Hellmund, Svetlana Krasovski-Nikiforovs, Mia Wintel, Sarah M Klaes, Merle Hoerig, Sophia Monert, Rolf Schwarzer and 5 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Andreas K Lindner *Institute of Tropical Medicine and International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany. andreas.lindner@charite.de.ORCID http://orcid.org/0000-0001-5768-5109
Navina Sarma *Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Luise Marie RustBerliner Stadtmission, Berlin, Germany.
Theresa HellmundBerliner Stadtmission, Berlin, Germany.
Svetlana Krasovski-NikiforovsBerliner Stadtmission, Berlin, Germany.
Mia WintelInstitute of Tropical Medicine and International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sarah M KlaesBerliner Stadtmission, Berlin, Germany.
Merle HoerigBerliner Stadtmission, Berlin, Germany.
Sophia MonertBerliner Stadtmission, Berlin, Germany.
Rolf SchwarzerLabor Berlin-Charité Vivantes GmbH, Berlin, Germany.
Anke EdelmannLabor Berlin-Charité Vivantes GmbH, Berlin, Germany.
Gabriela Equihua MartinezInstitute of Tropical Medicine and International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Frank P MockenhauptInstitute of Tropical Medicine and International Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Tobias KurthInstitute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Joachim SeyboldMedical Directorate, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLiving conditions in homeless shelters facilitate the transmission of COVID-19. Social determinants and pre-existing health conditions place homeless people at increased risk of severe disease. Described outbreaks in homeless shelters resulted in high proportions of infected residents and staff members. In addition to other infection prevention strategies, regular shelter-wide (universal) testing for COVID-19 may be valuable, depending on the level of community transmission and when resources permit.

methodsThis was a prospective feasibility cohort study to evaluate universal testing for COVID-19 at a homeless shelter with 106 beds in Berlin, Germany. Co-researchers were recruited from the shelter staff. A PCR analysis of saliva or self-collected nasal/oral swab was performed weekly over a period of 3 weeks in July 2020. Acceptability and implementation barriers were analyzed by process evaluation using mixed methods including evaluation sheets, focus group discussion and a structured questionnaire.

resultsNinety-three out of 124 (75%) residents were approached to participate in the study. Fifty-one out of the 93 residents (54.8%) gave written informed consent; thus 41.1% (51 out of 124) of all residents were included in the study. Among these, high retention rates (88.9-93.6%) of a weekly respiratory specimen were reached, but repeated collection attempts, as well as assistance were required. Around 48 person-hours were necessary for the sample collection including the preparation of materials. A self-collected nasal/oral swab was considered easier and more hygienic to collect than a saliva specimen. No resident was tested positive by RT-PCR. Language barriers were the main reason for non-participation. Flexibility of sample collection schedules, the use of video and audio materials, and concise written information were the main recommendations of the co-researchers for future implementation.

conclusionsVoluntary universal testing for COVID-19 is feasible in homeless shelters. Universal testing of high-risk facilities will require flexible approaches, considering the level of the community transmission, the available resources, and the local recommendations. Lack of human resources and laboratory capacity may be a major barrier for implementation of universal testing, requiring adapted approaches compared to standard individual testing. Assisted self-collection of specimens and barrier free communication may facilitate implementation in homeless shelters. Program planning must consider homeless people's needs and life situation, and guarantee confidentiality and autonomy.

Indexed as

COVID-19Ill-Housed PersonsCohort StudiesCOVID-19 TestingFeasibility StudiesGermanyHumansProspective StudiesSARS-CoV-2COVID-19HomelessnessHomeless shelterInfection controlMonitoringPandemicSARS-CoV-2

Identifiers

PMID34895157
PMCPMC8665323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.